NCT04270656View on ClinicalTrials.gov

Liver and Metabolic Effects of Insulin Pump Therapy in Diabetics Type 2 with Non-alcoholic Hepatic Steatosis

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 5, 2021

Primary Completion Date

September 23, 2024

Study Completion Date

September 23, 2024

Conditions
Type 2 Diabetes (T2D)
Interventions
PROCEDURE

Insulin pump therapy

5-day hospitalization in case of randomization in the insulin pump group (insulin pump establishing in according to the recommendations of the HAS)

PROCEDURE

Multi-injection treatment ( MDI ).

Corresponds to an outpatient visit if the patient is randomized into the multi-injection group

Trial Locations (9)

14033

CHU, Caen

17019

CHU, La Rochette

21000

CHU, Dijon

31059

CHU, Toulouse

35203

CHU de Rennes, Rennes

44093

Nantes UH, Nantes

49933

CHU, Angers

69495

Hospices Civils, Lyon

86000

CHU, Poitiers

All Listed Sponsors
collaborator

University Hospital, Angers

OTHER_GOV

lead

Nantes University Hospital

OTHER

NCT04270656 - Liver and Metabolic Effects of Insulin Pump Therapy in Diabetics Type 2 with Non-alcoholic Hepatic Steatosis | Biotech Hunter | Biotech Hunter